Sun Pharma arm launches plaque psoriasis treatment drug in Japan

In a regulatory filing, Sun Pharmaceutical Industries said its
"wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous
Injection 100 mg Syringe in Japan for the treatment of plaque
psoriasis in adult patients who have an inadequate response to
conventional therapies".

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-arm-launches-plaque-psoriasis-treatment-drug-in-japan/articleshow/78269005.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment